We are live on ! Find out more
MIM

Monashee Investment Management Portfolio holdings

AUM $184M
1-Year Est. Return 197.43%
This Fund
S&P 500
This Quarter Est. Return
+0.64%
1 Year Est. Return
+197.43%
3 Year Est. Return
+447.04%
5 Year Est. Return
+479.31%
10 Year Est. Return
+5,610.42%
AUM
$650M
AUM Growth
-$107M
Cap. Flow
-$73.7M
Cap. Flow %
-11.34%
Top 10 Hldgs %
28.5%
Holding
529
New
249
Increased
8
Reduced
22
Closed
155

Sector Composition

Rank Sector Weight
1 Healthcare 27.3%
2 Financials 11.86%
3 Technology 7.97%
4 Industrials 4.89%
5 Communication Services 3.88%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
NSTD.U
101
DELISTED
Northern Star Investment Corp. IV Units, each consisting of one share of Class A common stock and one-sixth of one redeemable warrant
NSTD.U
$1.98M 0.31%
+200,000
New +$2M
HIIIU
102
DELISTED
Hudson Executive Investment Corp. III Unit
HIIIU
$1.98M 0.31%
+200,000
New +$2.01M
CFVIU
103
DELISTED
CF Acquisition Corp. VI Unit
CFVIU
$1.98M 0.31%
+200,000
New +$2.03M
SES icon
104
SES AI
SES
$196M
$1.98M 0.3%
+199,995
New +$2.02M
VAQC
105
DELISTED
Vector Acquisition Corporation II Class A Ordinary Shares
VAQC
$1.98M 0.3%
+200,000
New +$1.99M
GNAC
106
DELISTED
Group Nine Acquisition Corp. Class A Common stock
GNAC
$1.97M 0.3%
+199,992
New +$1.98M
CRHC
107
DELISTED
Cohn Robbins Holdings Corp.
CRHC
$1.97M 0.3%
200,000
-199,993
-50% -$2.11M
FRGE
108
DELISTED
Forge Global Holdings
FRGE
$1.96M 0.3%
+13,333
New +$2.05M
BSN
109
DELISTED
Broadstone Acquisition Corp.
BSN
$1.96M 0.3%
199,998
ABX
110
Abacus Global Management
ABX
$913M
$1.96M 0.3%
200,000
-50,000
-20% -$511K
VINC
111
DELISTED
Vincerx Pharma, Inc. Common Stock
VINC
$1.93M 0.3%
5,000
-5,000
-50% -$2.02M
AKIC
112
DELISTED
Sports Ventures Acquisition Corp. Class A Ordinary Shares
AKIC
$1.92M 0.3%
+200,000
New +$1.97M
AVEO
113
DELISTED
AVEO Pharmaceuticals, Inc.
AVEO
$1.83M 0.28%
+250,000
New +$2.16M
CRCT icon
114
Cricut
CRCT
$1.24B
$1.78M 0.27%
+90,000
New +$1.66M
JOAN
115
DELISTED
JOANN, Inc. Common Stock
JOAN
$1.78M 0.27%
+175,000
New +$1.95M
OPCH icon
116
Option Care Health
OPCH
$3.67B
$1.77M 0.27%
100,000
-100,000
-50% -$1.87M
MACQU
117
DELISTED
MCAP Acquisition Corporation Unit
MACQU
$1.74M 0.27%
+175,000
New +$1.74M
SPTKU
118
DELISTED
SportsTek Acquisition Corp. Unit
SPTKU
$1.74M 0.27%
+175,000
New +$1.76M
PRQR icon
119
ProQR Therapeutics
PRQR
$255M
$1.65M 0.25%
+250,000
New +$1.28M
VEI
120
DELISTED
Vine Energy Inc.
VEI
$1.65M 0.25%
+120,000
New +$1.67M
IRON icon
121
Disc Medicine
IRON
$3.01B
$1.59M 0.24%
+3,915
New +$1.75M
VINP icon
122
Vinci Compass Investments Ltd
VINP
$656M
$1.58M 0.24%
+120,000
New +$1.95M
RACB
123
DELISTED
Research Alliance Corp. II Class A Common Stock
RACB
$1.54M 0.24%
+150,000
New +$1.54M
ME
124
DELISTED
23andMe Holding Co
ME
$1.53M 0.23%
+7,500
New +$1.83M
JELD icon
125
JELD-WEN Holding
JELD
$162M
$1.52M 0.23%
+55,000
New +$1.53M

Similar funds

Monashee Investment Management's Q1 2021 Portfolio in Review

As of Q1 2021, Monashee Investment Management held 529 positions worth $650M, down 14% from $757M the previous quarter. Its ten largest holdings account for 28% of the portfolio.

Monashee Investment Management withdrew a net $73.7M in Q1 2021, closing 155 positions and reducing 22 holdings. Its most notable exit was Sigilon Therapeutics, Inc. Common Stock, an estimated $27M position sold in full.

By sector, the portfolio is most concentrated in Healthcare at 27% of assets, down from 30% a quarter earlier, followed by Financials and Technology.

Against the trend, Monashee Investment Management opened a new position in Beam Therapeutics worth $21.5M.

  • Monashee Investment Management's largest Q1 2021 buy was Beam Therapeutics: 268,820 shares worth $21.5M.
  • Monashee Investment Management added most to View, Inc. Class A Common Stock in Q1 2021, an estimated $11.9M increase.
  • Monashee Investment Management's biggest Q1 2021 reduction was Vanguard Morningstar Total Stock Market ETF, cutting an estimated $53.1M.
  • Monashee Investment Management fully exited Sigilon Therapeutics, Inc. Common Stock in Q1 2021, selling an estimated $27M.
  • Monashee Investment Management's ten largest holdings make up 28% of its $650M portfolio in Q1 2021.
  • Monashee Investment Management opened 249 new positions and closed 155 in Q1 2021.
  • Monashee Investment Management's portfolio value fell 14% quarter-over-quarter to $650M.

Based on Monashee Investment Management's 13F filing for Q1 2021, filed 14 May 2021.